Jean‐Michel Halimi

Author

Jean‐Michel Halimi

Centre Hospitalier Universitaire de Tours ORCID

Also Known As

David Montaigne, F. Azizi, Halimi, J-M. (Jean-Michel), Halimi, J.-M., Halimi, Jean-Michel, J Halimi, J M Halimi, J M. Halimi, J. -M. Halimi, J. Halimi

406

Publications

17.3K

Citations

H-Index

119

Concepts

All Affiliations

Centre Hospitalier Universitaire de Tours Université de Tours Inserm Assistance Publique – Hôpitaux de Paris Hôpital Bretonneau

About

Jean‐Michel Halimi is an author at Centre Hospitalier Universitaire de Tours specializing in medicine, nephrology, and chronic kidney disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	39	2.4K
2	Public Health	10	10	538
3	Health Sciences	2	2	28
4	Natural Sciences	1	1	12
5	Biochemistry	1	1	12

Jean‐Michel Halimi

116

Publications

5.6K

Citations

H-Index

Page 1

	Year	Citations
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress, The Lancet UrologyRenal DiseaseRenal EventsRenal FunctionDiabetes	2019	589
Effects of current smoking and smoking discontinuation on renal function and proteinuria in the general population Jean‐Michel Halimi, Bruno Giraudeau, Sylviane Vol, Kidney International Tobacco ControlHemodialysisUrologyRenal DiseaseGlomerulonephritis	2000	190
Acute Renal Infarction Marie Bourgault, Philippe Grimbert, C. Verret, Clinical Journal of the American Society of Nephrology	2012	172
Etiology and Outcomes of Thrombotic Microangiopathies Guillaume Bayer, Florent Von Tokarski, Benjamin Thoreau, Clinical Journal of the American Society of Nephrology	2019	155
Adherence to Antihypertensive Treatment and the Blood Pressure–Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial Michel Azizi, Héléna Pereira, Idir Hamdidouche, Circulation	2016	153
Preemptive rituximab prevents long-term relapses in immune-mediated thrombotic thrombocytopenic purpura Matthieu Jestin, Y. Benhamou, An‐Sofie Schelpe, Blood	2018	149
Early Low‐Grade Proteinuria: Causes, Short‐Term Evolution and Long‐Term Consequences in Renal Transplantation Jean‐Michel Halimi, I. Laouad, Matthias Büchler, American Journal of Transplantation Glomerular DiseaseGlomerulonephritisUrologyRenal DiseaseRenal Function	2005	142
Cardiac troponin‐I on diagnosis predicts early death and refractoriness in acquired thrombotic thrombocytopenic purpura. Experience of the French Thrombotic Microangiopathies Reference Center Y. Benhamou, Pierre‐Yves Boëlle, B. Baudin, Journal of Thrombosis and Haemostasis ThrombosisCardiovascular DiseaseHematologyPathologyCardiac Troponin‐i	2014	136
Waist circumference and the metabolic syndrome predict the development of elevated albuminuria in non-diabetic subjects: the DESIR Study Fabrice Bonnet, Michel Marre, Jean‐Michel Halimi, Journal of Hypertension	2006	122
Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors Alice Le Clech, Noémie Simon‐Tillaux, François Provôt, Kidney International HemodialysisUrologyHaplotype DeterminationGenetic DisorderMedicine	2019	113

Page 1